Global Vaccine Adjuvants Market Research Report to 2021

August 2016 | 103 pages | ID: G0C9EF52720EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Vaccine Adjuvants

Revenue, means the sales value of Vaccine Adjuvants

This report studies Vaccine Adjuvants in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Brenntag Biosector
• Seppic
• CSL Limited
• Agenus Inc
• Novavax Inc
• Invivogen
• SPI Pharma Inc
• Avanti Polar Lipids Inc
• MPV Technologies Inc
• OZ Biosciences

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Vaccine Adjuvants in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Pathogen Components
• Adjuvant Emulsions
• Particulate Adjuvants
• Combination Adjuvants
• Others

Split by application, this report focuses on sales, market share and growth rate of Vaccine Adjuvants in each application, can be divided into

• Research Applications
• Commercial Applications
• Others

Contents

Global Vaccine Adjuvants Market Research Report 2021

1 VACCINE ADJUVANTS OVERVIEW

1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Vaccine Adjuvants Segment by Types
  1.2.1 Global Sales Market Share of Vaccine Adjuvants by Type in 2015
  1.2.2 Pathogen Components
  1.2.3 Adjuvant Emulsions
  1.2.4 Particulate Adjuvants
  1.2.5 Combination Adjuvants
  1.2.6 Others
1.3 Vaccine Adjuvants Segment by Applications
  1.3.1 Research Applications
  1.3.2 Commercial Applications
  1.3.3 Others
1.4 Vaccine Adjuvants Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Vaccine Adjuvants (2011-2021)
  1.5.1 Global Vaccine Adjuvants Sales and Revenue (2011-2021)
  1.5.2 Global Vaccine Adjuvants Sales and Growth Rate (2011-2021)
  1.5.3 Global Vaccine Adjuvants Revenue and Growth Rate (2011-2021)

2 GLOBAL VACCINE ADJUVANTS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Vaccine Adjuvants Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Vaccine Adjuvants Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Vaccine Adjuvants Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL VACCINE ADJUVANTS ANALYSIS BY REGION

3.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Vaccine Adjuvants Sales Market Share by Region (2011-2021)
  3.1.2 Global Vaccine Adjuvants Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
  3.2.2 North America Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
  3.4.2 China Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
  3.6.2 India Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL VACCINE ADJUVANTS ANALYSIS BY TYPE

4.1 Global Vaccine Adjuvants Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Vaccine Adjuvants Sales and Market Share by Type (2011-2021)
  4.1.2 Global Vaccine Adjuvants Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Pathogen Components Sales, Revenue, Price and Growth (2011-2021)
4.3 Adjuvant Emulsions Sales, Revenue, Price and Growth (2011-2021)
4.4 Particulate Adjuvants Sales, Revenue, Price and Growth (2011-2021)
4.5 Combination Adjuvants Sales, Revenue, Price and Growth (2011-2021)
4.6 Others Sales, Revenue, Price and Growth (2011-2021)

5 GLOBAL VACCINE ADJUVANTS MARKET ANALYSIS BY APPLICATION

5.1 Global Vaccine Adjuvants Sales and Market Share by Application (2011-2021)
5.2 Major Regions Vaccine Adjuvants Sales by Application in 2015 and 2016
  5.2.1 North America Vaccine Adjuvants Sales by Application
  5.2.2 Europe Vaccine Adjuvants Sales by Application
  5.2.3 China Vaccine Adjuvants Sales by Application
  5.2.4 Japan Vaccine Adjuvants Sales by Application
  5.2.5 India Vaccine Adjuvants Sales by Application
  5.2.6 Southeast Asia Vaccine Adjuvants Sales by Application

6 GLOBAL VACCINE ADJUVANTS MANUFACTURERS ANALYSIS

6.1 Brenntag Biosector
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Vaccine Adjuvants Product Overview
    6.1.2.1 Pathogen Components
    6.1.2.2 Adjuvant Emulsions
    6.1.2.3 Particulate Adjuvants
  6.1.3 Vaccine Adjuvants Sales, Revenue, Price of Brenntag Biosector (2015 and 2016)
6.2 Seppic
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Vaccine Adjuvants Product Overview
    6.2.2.1 Pathogen Components
    6.2.2.2 Adjuvant Emulsions
    6.2.2.3 Particulate Adjuvants
  6.2.3 Vaccine Adjuvants Sales, Revenue, Price of Seppic (2015 and 2016)
6.3 CSL Limited
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Vaccine Adjuvants Product Overview
    6.3.2.1 Pathogen Components
    6.3.2.2 Adjuvant Emulsions
    6.3.2.3 Particulate Adjuvants
  6.3.3 Vaccine Adjuvants Sales, Revenue, Price of CSL Limited (2015 and 2016)
6.4 Agenus Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Vaccine Adjuvants Product Overview
    6.4.2.1 Pathogen Components
    6.4.2.2 Adjuvant Emulsions
  6.4.3 Vaccine Adjuvants Sales, Revenue, Price of Agenus Inc (2015 and 2016)
6.5 Novavax Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Vaccine Adjuvants Product Overview
    6.5.2.1 Pathogen Components
    6.5.2.2 Adjuvant Emulsions
  6.5.3 Vaccine Adjuvants Sales, Revenue, Price of Novavax Inc (2015 and 2016)
6.6 Invivogen
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Vaccine Adjuvants Product Overview
    6.6.2.1 Pathogen Components
    6.6.2.2 Adjuvant Emulsions
  6.6.3 Vaccine Adjuvants Sales, Revenue, Price of Invivogen (2015 and 2016)
6.7 SPI Pharma Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Vaccine Adjuvants Product Overview
    6.7.2.1 Pathogen Components
    6.7.2.2 Adjuvant Emulsions
  6.7.3 Vaccine Adjuvants Sales, Revenue, Price of SPI Pharma Inc (2015 and 2016)
6.8 Avanti Polar Lipids Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Vaccine Adjuvants Product Overview
    6.8.2.1 Pathogen Components
    6.8.2.2 Adjuvant Emulsions
  6.8.3 Vaccine Adjuvants Sales, Revenue, Price of Avanti Polar Lipids Inc (2015 and 2016)
6.9 MPV Technologies Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Vaccine Adjuvants Product Overview
    6.9.2.1 Pathogen Components
    6.9.2.2 Adjuvant Emulsions
  6.9.3 Vaccine Adjuvants Sales, Revenue, Price of MPV Technologies Inc (2015 and 2016)
6.10 OZ Biosciences
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Vaccine Adjuvants Product Overview
    6.10.2.1 Pathogen Components
    6.10.2.2 Adjuvant Emulsions
  6.10.3 Vaccine Adjuvants Sales, Revenue, Price of OZ Biosciences (2015 and 2016)

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Vaccine Adjuvants
Figure Global Sales Market Share of Vaccine Adjuvants by Type in 2015
Table Vaccine Adjuvants Product Type of by Manufacturers
Table Vaccine Adjuvants Sales Market Share by Application in 2015 and 2016
Figure North America Vaccine Adjuvants Revenue and Growth Rate (2011-2021)
Figure China Vaccine Adjuvants Revenue and Growth Rate (2011-2021)
Figure Europe Vaccine Adjuvants Revenue and Growth Rate (2011-2021)
Figure Japan Vaccine Adjuvants Revenue and Growth Rate (2011-2021)
Figure India Vaccine Adjuvants Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Vaccine Adjuvants Revenue and Growth Rate (2011-2021)
Table Global Vaccine Adjuvants Sales and Revenue (2011-2021)
Figure Global Vaccine Adjuvants Sales and Growth Rate (2011-2021)
Figure Global Vaccine Adjuvants Revenue and Growth Rate (2011-2021)
Table Global Vaccine Adjuvants Sales of Key Manufacturers (2015 and 2016)
Table Global Vaccine Adjuvants Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Vaccine Adjuvants Sales Share by Manufacturers
Figure 2016 Vaccine Adjuvants Sales Share by Manufacturers
Table Global Vaccine Adjuvants Revenue by Manufacturers (2015 and 2016)
Table Global Vaccine Adjuvants Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Vaccine Adjuvants Revenue Share by Manufacturers
Table 2016 Global Vaccine Adjuvants Revenue Share by Manufacturers
Table Manufacturers Vaccine Adjuvants Manufacturing Base Distribution and Product Type
Table Global Vaccine Adjuvants Sales Market by Region (2011-2021)
Figure Global Vaccine Adjuvants Sales Market by Region (2011-2021)
Figure Global Vaccine Adjuvants Sales Market Share by Region (2011-2021)
Table Global Vaccine Adjuvants Revenue Market by Region (2011-2021)
Table Global Vaccine Adjuvants Revenue Market Share by Region (2011-2021)
Table North America Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
Figure North America Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
Table Europe Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
Figure Europe Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
Table China Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
Figure China Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
Table Japan Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
Figure Japan Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
Table India Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
Figure India Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Vaccine Adjuvants Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Vaccine Adjuvants Sales, Revenue and Growth Rate (2011-2021)
Table Global Vaccine Adjuvants Sales by Type (2011-2021)
Table Global Vaccine Adjuvants Sales Share by Type (2011-2021)
Figure Sales Market Share of Vaccine Adjuvants by Type (2011-2021)
Figure Global Vaccine Adjuvants Sales Growth Rate by Type (2011-2021)
Table Global Vaccine Adjuvants Revenue by Type (2011-2021)
Table Global Vaccine Adjuvants Revenue Share by Type (2011-2021)
Figure Global Vaccine Adjuvants Revenue Growth Rate by Type (2011-2021)
Figure Pathogen Components Sales, Revenue and Growth (2011-2021)
Figure Pathogen Components Price Trend (2011-2021)
Figure Adjuvant Emulsions Sales, Revenue and Growth (2011-2021)
Figure Adjuvant Emulsions Price Trend (2011-2021)
Figure Particulate Adjuvants Sales, Revenue and Growth (2011-2021)
Figure Particulate Adjuvants Price Trend (2011-2021)
Figure Combination Adjuvants Sales, Revenue and Growth (2011-2021)
Figure Combination Adjuvants Price Trend (2011-2021)
Figure Others Sales, Revenue and Growth (2011-2021)
Figure Others Price Trend (2011-2021)
Table Global Vaccine Adjuvants Sales by Application (2011-2021)
Table Global Vaccine Adjuvants Sales Market Share by Application (2011-2021)
Figure Global Vaccine Adjuvants Sales Market Share by Application in 2015
Figure Global Vaccine Adjuvants Sales Market Share by Application in 2021
Table North America Vaccine Adjuvants Sales by Application (2015 and 2016)
Table Europe Vaccine Adjuvants Sales by Application (2015 and 2016)
Table China Vaccine Adjuvants Sales by Application (2015 and 2016)
Table Japan Vaccine Adjuvants Sales by Application (2015 and 2016)
Table India Vaccine Adjuvants Sales by Application (2015 and 2016)
Table Southeast Asia Vaccine Adjuvants Sales by Application (2015 and 2016)
Table Global Vaccine Adjuvants Sales Growth Rate by Application (2011-2021)
Figure Global Vaccine Adjuvants Sales Growth Rate by Application (2011-2021)
Table Brenntag Biosector Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of Brenntag Biosector (2015 and 2016)
Table Seppic Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of Seppic (2015 and 2016)
Table CSL Limited Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Agenus Inc Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of Agenus Inc (2015 and 2016)
Table Novavax Inc Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of Novavax Inc (2015 and 2016)
Table Invivogen Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of Invivogen (2015 and 2016)
Table SPI Pharma Inc Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of SPI Pharma Inc (2015 and 2016)
Table Avanti Polar Lipids Inc Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of Avanti Polar Lipids Inc (2015 and 2016)
Table MPV Technologies Inc Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of MPV Technologies Inc (2015 and 2016)
Table OZ Biosciences Basic Information List
Table Vaccine Adjuvants Sales, Revenue, Price of OZ Biosciences (2015 and 2016)